Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Optiscan Imaging Ltd

Technology AU OIL

0.09AUD
-0.007(7.22%)

Last update at 2026-03-11T02:53:00Z

Day Range

0.090.10
LowHigh

52 Week Range

0.080.15
LowHigh

Fundamentals

  • Previous Close 0.10
  • Market Cap89.80M
  • Volume126032
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-7.63856M
  • Revenue TTM2.44M
  • Revenue Per Share TTM0.003
  • Gross Profit TTM 2.03M
  • Diluted EPS TTM-0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -6.29162M -6.06050M -4.35150M -4.23304M -2.12669M
Minority interest - - - - -
Net income -6.31195M -6.06050M -4.35150M -4.23304M -2.12669M
Selling general administrative 4.17M 4.35M 3.60M 1.65M 1.67M
Selling and marketing expenses 0.16M 0.23M - - -
Gross profit 3.25M 0.63M 1.13M -2.68591M -0.41014M
Reconciled depreciation 0.43M 0.57M 0.38M 0.24M 0.24M
Ebit -6.60038M -7.03145M -4.31921M -4.20088M -2.07043M
Ebitda -6.49256M -6.46415M -3.94039M -3.96033M -1.83214M
Depreciation and amortization 0.11M 0.57M 0.38M 0.24M 0.24M
Non operating income net other - - - - -
Operating income -6.17082M -8.41485M -4.35035M -4.23209M -2.36443M
Other operating expenses 9.90M 9.57M 0.87M 0.93M 1.74M
Interest expense 0.03M 0.02M 0.03M 0.03M 0.06M
Tax provision 0.02M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.33M 0.55M 0.03M 0.02M 0.04M
Net interest income 0.31M 0.52M -0.00115M -0.01117M -0.03949M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.02M -0.99466M 0.97M 1.28M 1.69M
Total revenue 3.72M 1.16M 1.68M 1.01M 0.89M
Total operating expenses 9.42M 9.04M 6.42M 6.48M 4.61M
Cost of revenue 0.47M 0.53M 0.55M 3.70M 1.30M
Total other income expense net -0.12079M 2.35M 0.94M 1.25M 1.64M
Discontinued operations - - - - -
Net income from continuing ops -6.31195M -6.06050M -4.35150M -4.23304M -2.12669M
Net income applicable to common shares -6.31195M -6.06050M -4.35150M -4.23304M -2.12669M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 10.56M 15.63M 4.67M 7.98M 11.70M
Intangible assets 0.00470M - 0.45M 0.45M -
Earning assets - - - - -
Other current assets 0.51M 5.40M 0.30M 0.11M 0.12M
Total liab 2.84M 1.76M 1.63M 1.39M 1.48M
Total stockholder equity 7.71M 13.87M 3.04M 6.59M 10.22M
Deferred long term liab - - - - -
Other current liab - 0.99M 0.90M 0.72M 0.58M
Common stock - 88.53M 71.86M 71.26M 70.94M
Capital stock 88.53M - 71.86M 71.26M 70.94M
Retained earnings -81.30600M -75.23912M -70.94207M -66.89364M -62.66060M
Other liab - - 0.02M 0.02M 0.01M
Good will - - - - -
Other assets - - 0.00000M 0.05M 0.05M
Cash 4.55M 6.10M 0.88M 4.53M 8.44M
Cash and equivalents - - - - 8.44M
Total current liabilities 1.51M 1.75M 1.42M 1.00M 0.97M
Current deferred revenue - - -0.23169M -0.19923M -0.17209M
Net debt - -5.88023M -0.46308M -3.98054M -7.77431M
Short term debt - 0.22M 0.23M 0.18M 0.17M
Short long term debt 0.03M - 0.04M - -
Short long term debt total - 0.22M 0.41M 0.55M 0.67M
Other stockholder equity - - -0.92128M -4.36243M -8.28163M
Property plant equipment - - 0.58M 0.61M 0.68M
Total current assets 8.86M 15.07M 3.65M 7.32M 10.97M
Long term investments - - - 0.05M 0.05M
Net tangible assets - - 2.59M 6.59M 10.22M
Short term investments - - 0.05M 0.05M -
Net receivables 0.32M 1.57M 0.98M 1.41M 1.24M
Long term debt - - - - -
Inventory 1.67M 2.00M 1.44M 1.27M 1.16M
Accounts payable 0.37M 0.54M 0.52M 0.30M 0.40M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 0.58M 2.12M 2.23M 1.94M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 0.16M -1.02573M -0.45000M -
Deferred long term asset charges - - - - -
Non current assets total 1.69M 0.56M 1.03M 0.66M 0.73M
Capital lease obligations 1.45M - 0.37M 0.55M 0.67M
Long term debt total - - 0.18M 0.37M 0.50M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments 5.05M -5.23286M -0.12686M -0.12414M -0.03087M
Change to liabilities - - 0.37M -0.06969M 0.04M
Total cashflows from investing activities 5.05M -5.23286M -0.12686M -0.12414M -0.03087M
Net borrowings -0.16884M -0.20359M -0.41548M -0.20015M -0.54853M
Total cash from financing activities -0.38191M 16.21M -0.37448M 0.04M 10.07M
Change to operating activities - - -0.15979M 0.10M 0.00755M
Net income -6.31195M -6.06050M -4.35150M -4.23304M -2.12669M
Change in cash -1.54938M 5.23M -3.65384M -3.91312M 7.92M
Begin period cash flow 6.10M 0.88M 4.53M 8.44M 0.53M
End period cash flow 4.55M 6.10M 0.88M 4.53M 8.44M
Total cash from operating activities -6.21203M -5.74445M -3.16455M -3.83358M -2.12631M
Issuance of capital stock - 16.72M 0.04M 0.24M 11.04M
Depreciation 0.43M 0.57M 0.38M 0.24M 0.24M
Other cashflows from investing activities 5.14M -5.14551M - - -
Dividends paid - - - 0.42M 0.20M
Change to inventory 0.33M -0.56262M -0.16833M -0.10835M -0.00655M
Change to account receivables -0.56172M -0.59187M 0.44M -0.16893M -0.48560M
Sale purchase of stock 0.00000M -0.10450M 0.04M -0.20015M -0.42329M
Other cashflows from financing activities -0.16884M -0.20743M -0.22730M -0.12414M 0.23M
Change to netincome - - 0.32M 0.41M 0.21M
Capital expenditures 0.09M 0.09M 0.13M 0.12M 0.03M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.43463M -0.53736M 0.27M -0.27728M -0.49215M
Stock based compensation 0.16M 0.23M 0.23M 0.38M 0.17M
Other non cash items -0.05212M 0.29M 0.81M 0.16M -0.23790M
Free cash flow -6.30510M -5.83180M -3.29141M -3.95771M -2.15718M

Peer Comparison

Sector: Technology Industry: Scientific & Technical Instruments

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
OIL
Optiscan Imaging Ltd		 -0.007 7.22% 0.09 - 10.82 36.83 4.03 104.02 -12.1087
CDA
Codan Ltd		 0.75 2.12% 36.08 53.11 35.34 8.87 12.25 9.14 38.92
CAT
Catapult Group International Ltd		 -0.15 3.85% 3.75 - 105.26 8.85 6.52 5.64 37.79
IKE
Ikegps Group Ltd		 0.01 1.80% 0.85 - - 6.57 6.92 5.52 -3.6167
SMN
Structural Monitoring Systems Plc		 -0.005 1.28% 0.39 19.00 3.23 2.11 2.61 2.38 18.22

Reports Covered

Stock Research & News

View All

Profile

Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Germany, China, Australia, and the United States. It offers InVue, a microscopic medical imaging device for precision surgery; InForm, a digital pathology imaging device for pathology workflows; InVivage, an intra-oral endomicroscope for oral imaging solutions; and ViewnVivo, a miniaturized in vivo imaging device for life sciences, pre-clinical and translational research. The company also provides InSpecta, a novel digital microscopic imaging device for veterinary medicine. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.

Optiscan Imaging Ltd

16 Miles Street, Mulgrave, VIC, Australia, 3170

Key Executives

Name Title Year Born
Prof. Camile Farah M.A.I.C.D., M.B.A., Ph.D. CEO, MD & Exec. Director NA
Mr. Justin Mouchacca B.Bus (Acc), C.A., CA Company Sec. NA
Prof. Camile Farah M.A.I.C.D., M.B.A., Ph.D. CEO, MD & Executive Director NA
Mr. Brendan Fafiani Chief Operating Officer NA
Mr. Justin Mouchacca B.Bus (Acc), C.A., CA Company Secretary NA
Prof. Camile Farah M.A.I.C.D., M.B.A., Ph.D. CEO, MD & Executive Director NA
Mr. Brendan Fafiani Chief Operating Officer NA
Mr. Justin Mouchacca B.Bus (Acc), C.A., CA Company Secretary NA
Prof. Camile Farah M.A.I.C.D., M.B.A., Ph.D. CEO, MD & Executive Director NA
Mr. Brendan Fafiani Chief Operating Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.